vTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio
HIGH POINT, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that vTv Therapeutics LLC (“vTv”)...
Day: December 15, 2020
Microbix Presenting Product Results at AACC
Reporting on Test-Workflow Controls for Important Sexually-Transmitted InfectionsMISSISSAUGA, Ontario, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX,...
Skylight Health Receives Conditional Approval of TSX Venture Listing
Skylight Health has been granted conditional approval for listing on the TSX Venture ExchangeCompany expects to commence trading on the...
Neovasc Announces First Neovasc Reducer™ Implants in France
VANCOUVER and MINNEAPOLIS, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced...
Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
New Scientific Advisory Board of Immuno-Inflammatory ExpertsPreliminary Topline Data for the ATI-450-RA-201 Trial Expected in January 2021WAYNE, Pa., Dec. 15,...
Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
Klisyri® is the first FDA approved proprietary product for AthenexFirst-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis...
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I Efficacy endpoints demonstrated...
Izotropic Reports High Degree of Confidence After Pre-Submission Meeting with FDA
Vancouver, British Columbia--(Newsfile Corp. - December 15, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or...
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of,...
Tandigm Health Partners with Care Continuity for Patient Navigation and Care Logistics
Consultation Management Platform Enhancing Communication and Care Management WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Tandigm Health, a leading population health services organization, today...
Model N Welcomes Manisha Shetty Gulati as New Board Member
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced the appointment of...
Chi Arthritis & Rheumatology able to see more patients and support new E/M coding using mobile AI voice assistant from Saykara
The largest single-specialty provider of rheumatology services in Arkansas has automated clinical charting with the Saykara mobile AI voice assistant,...
Avellino Expands Its Board of Directors and Welcomes New Executive Management Members
MENLO PARK, Calif.--(BUSINESS WIRE)--#avagen--Avellino announced today the appointment of three new members to its Board of Directors. In addition, the...
National Health Investors: NHI Announces Fourth Quarter Dividend
MURFREESBORO, TN / ACCESSWIRE / December 15, 2020 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay...
Resilient Healthcare: The 2018 Healthcare Solution that Solved the 2020 Global Pandemic Challenge
PLANO, TX / ACCESSWIRE / December 15, 2020 / Known for pioneering North Texas' in-home COVID-19 testing and managing COVID-19...